 | Supply fears lead EU vaccine industry to seek home comforts
finance.yahoo.com - September 17 at 3:28 AM |
 | MERCK Kommanditgesellschaft auf Aktien (FRA:MRK) Stock Passes Above 50 Day Moving Average of $185.65
americanbankingnews.com - September 15 at 2:00 AM |
| MORNING BID-A tense finish
finance.yahoo.com - June 29 at 4:28 AM |
| Signature Resources Announces $3.5 Million Non-Brokered Private Placement LED by Commodity Discovery Fund, Funds Managed by Sprott Asset Management LP & Crescat Capital
finance.yahoo.com - June 21 at 9:29 AM |
| This New Product Is Central to mRNA Vaccines -- But Should You Buy the Stock?
finance.yahoo.com - June 9 at 12:27 PM |
| UPDATE 1-Lab supplier Merck KGaA says U.S. Defense Production Act poses challenge
finance.yahoo.com - May 12 at 7:00 AM |
| MORNING BID-Covid, missiles and tanker tailbacks
finance.yahoo.com - March 25 at 4:39 AM |
| MERCK Kommanditgesellschaft auf Aktien (MRK1N.MX)
ca.finance.yahoo.com - March 11 at 8:40 AM |
| Germany's Merck KGaA predicts earnings gain in 2021 on lab gear
finance.yahoo.com - March 4 at 4:25 AM |
|
 | Hydrophobic Interaction Chromatography Resins Market (2020-29): Demand and Scope, Industry Trends and Threats | Tosoh Corporation, Pall Corporation
marketwatch.com - December 27 at 1:06 AM |
| Superdisintegrants Market (2020-29): Extensive Growth, Rising Demand and Strategies | BASF SE, DFE Pharma
marketwatch.com - December 25 at 7:16 AM |
| MERCK Kommanditgesellschaft auf Aktien: Merck KGaA Benefiting From COVID-Related Development Projects; Maintaining Fair Value Estimate
finance.yahoo.com - November 14 at 10:38 PM |
 | Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe
markets.businessinsider.com - November 3 at 4:14 AM |
 | Merck sets ultra-high bar with impressive development of Keytruda
seekingalpha.com - October 31 at 7:26 PM |
| Merck sets ulta-high bar with impressive development of Keytruda
seekingalpha.com - October 30 at 12:22 PM |
| Merck EPS beats by $0.31, beats on revenue
seekingalpha.com - October 28 at 12:29 PM |
 | Merck says early data from COVID-19 vaccines expected this year
reuters.com - October 28 at 7:24 AM |
| Merck up 2% premarket on Q3 beat; FY20 non-GAAP EPS guidance raised
seekingalpha.com - October 27 at 10:01 AM |
| Merck quarterly profit rises nearly 55% as key drug sales rebound
reuters.com - October 27 at 10:01 AM |
| Merck raises annual profit outlook as Keytruda drives profit beat
reuters.com - October 27 at 10:01 AM |
| Merck Q3 2020 Earnings Preview
seekingalpha.com - October 26 at 5:23 PM |
| Merck Reports Positive Data From 2 Trials Of V114 Pneumococcal Conjugate Vaccine
markets.businessinsider.com - October 20 at 7:36 AM |
| Merck's 15-valent pneumonia vaccine successful in two more late-stage studies
seekingalpha.com - October 20 at 7:36 AM |
| Merck's Keytruda/chemo combo shows durable, sustained benefit in long term lung cancer study
seekingalpha.com - October 16 at 6:55 PM |
| MERCK KGAA Inhaber-Aktien o.N. (MRK.SG)
ca.finance.yahoo.com - October 16 at 1:55 PM |
 | A German drugmaker just increased its stake in this Md. biopharma — and it showed in the stock price
bizjournals.com - October 12 at 4:56 PM |
| Merck HIV combo regimen shows sustained benefit in mid-stage HIV study
seekingalpha.com - October 8 at 12:47 PM |
|
 | Merck Mid-stage HIV Study On Islatravir- Doravirine Shows Viral Suppression Maintained
nasdaq.com - October 8 at 12:47 PM |
 | New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
baystreet.ca - October 7 at 11:43 AM |
 | Merck Inc (MRK) EVP, Global Svcs & CFO Robert M Davis Sold $20.4 million of Shares
uk.finance.yahoo.com - October 6 at 10:49 PM |
| Merck Banks on Keytruda, Pipeline & Deals Amid Generic Woes
nasdaq.com - October 2 at 12:44 PM |
| Celyad-Merck Team Up to Evaluate CYAD-101 in Colorectal Cancer
nasdaq.com - September 29 at 7:30 PM |
| Merck Enbrel biosimilar OK'd in Canada for four new uses
seekingalpha.com - September 15 at 8:56 AM |
| Merck: Health Canada Approves BRENZYS For Four New Indications
nasdaq.com - September 15 at 8:56 AM |
 | Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine
fool.com - September 14 at 12:16 AM |
| Merck: Gefapixant Significantly Reduced Cough Frequency Compared To Placebo In Two Phase 3 Trials
nasdaq.com - September 8 at 9:19 AM |
| Merck To Present New Data From Oncology Development Program At ESMO Virtual Congress
nasdaq.com - September 2 at 10:11 AM |
| Why Is Merck (MRK) Up 8.4% Since Last Earnings Report?
nasdaq.com - August 30 at 2:53 PM |
| Merck : Phase 3 Study Of KEYTRUDA - Chemotherapy On Metastatic Esophageal Cancer Meets Main Goal
nasdaq.com - August 19 at 8:20 AM |
| Merck in-licenses NASH candidate from Hanmi Pharmaceutical
seekingalpha.com - August 4 at 7:29 AM |
 | Goldman Sachs Upgrades Merck On Cancer, HIV, COVID-19 Pipeline
www.msn.com - August 3 at 1:09 PM |
 | Merck Posts Second-Quarter Earnings Beat and Lifts Guidance
www.thestreet.com - July 31 at 8:04 AM |
 | Pharma giant Merck raises 2020 outlook, saying the worst of the coronavirus impact is behind it
www.cnbc.com - July 31 at 8:04 AM |
| Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline
www.nasdaq.com - July 24 at 2:53 PM |
| New Research for Immunotherapy Combinations with Paclitaxel Helping in Breast Cancer Fight
www.marketwatch.com - July 21 at 8:41 AM |
| Novocure teams up with Merck in lung cancer study
seekingalpha.com - July 15 at 9:08 AM |
| Merck: Amazing Oncology Division, Underwhelming Dividend Opportunity
seekingalpha.com - July 9 at 1:04 PM |
| Pfizer's sBLA for Bavencio Gets FDA Nod, Daurismo Gets EU Nod
finance.yahoo.com - July 3 at 5:51 PM |
| Merck's Keytruda Wins FDA Nod for Squamous Cell Skin Cancer
www.nasdaq.com - June 25 at 1:18 PM |
| Merck teams up with Yumanity in neurodegenerative diseases
seekingalpha.com - June 24 at 12:14 PM |
